Related references
Note: Only part of the references are listed.Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
Longfei Jia et al.
ALZHEIMERS & DEMENTIA (2021)
Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis
German Plascencia-Villa et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers
Carmen Pena-Bautista et al.
JOURNAL OF NEUROCHEMISTRY (2021)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative
Thomas K. Karikari et al.
MOLECULAR PSYCHIATRY (2021)
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer's disease
Hao Hu et al.
TRANSLATIONAL PSYCHIATRY (2021)
Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70
Ashvini Keshavan et al.
BRAIN (2021)
Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70
Ashvini Keshavan et al.
BRAIN (2021)
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease
Carmen Pena-Bautista et al.
ANTIOXIDANTS (2020)
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis
Carmen Pena-Bautista et al.
ANTIOXIDANTS (2020)
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease
Yen Ying Lim et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia
Ya-Hui Ma et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2020)
Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker
Carmen Pena-Bautista et al.
JOURNAL OF PROTEOMICS (2019)
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
Alden L. Gross et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Lipid peroxidation in neurodegeneration
Carmen Pena-Bautista et al.
CLINICA CHIMICA ACTA (2019)
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease
Pratishtha Chatterjee et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease
Emily Eruysal et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection
Carmen Pena-Bautista et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
Saima Hilal et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Alzheimer's disease: A matter of blood-brain barrier dysfunction?
Axel Montagne et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease
Ana Garcia-Blanco et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Relation of Plasma Selenium and Lipid Peroxidation End Products in Patients With Alzheimer's Disease
Z. Chmatalova et al.
PHYSIOLOGICAL RESEARCH (2017)
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease
Hugo Lovheim et al.
ALZHEIMERS & DEMENTIA (2017)
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis
Petroula Proitsi et al.
ALZHEIMERS & DEMENTIA (2017)
Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease
Edward J. Goetzl et al.
NEUROLOGY (2015)
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease
Massimo S. Fiandaca et al.
FRONTIERS IN NEUROLOGY (2015)
Plasma phospholipids identify antecedent memory impairment in older adults
Mark Mapstone et al.
NATURE MEDICINE (2014)
Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis
Hua Cheng et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Alzheimers Disease: Pathological Mechanisms and Recent Insights
Dana M. Niedowicz et al.
Current Neuropharmacology (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Share Paper
